Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy / 药学学报
Acta Pharmaceutica Sinica
;
(12): 1091-1098, 2013.
Article
Dans Chinois
| WPRIM
| ID: wpr-259510
ABSTRACT
Current trends in nanotechnology and RNA interference technology have made the application of nanocarriers (NCS) as a novel gene and drug delivery systems very promising for the field of multidrug resistance (MDR) cancer treatment. Co-delivery of gene and chemotherapy drugs with NCS has a good synergistic effect compared with the traditional chemotherapy which can increase the amount of the drug distribution in target organ in order to reduce the toxic side effects thereby enhancing efficacy. Therefore, the advent of co-delivery systems with NCS especially in the clinical treatment of MDR has had a significant impact on the cancer treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Thérapeutique
/
Vecteurs de médicaments
/
Thérapie génétique
/
Chimie
/
Systèmes de délivrance de médicaments
/
Multirésistance aux médicaments
/
Résistance aux médicaments antinéoplasiques
/
Nanotechnologie
/
Petit ARN interférent
/
Interférence par ARN
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Acta Pharmaceutica Sinica
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS